Silveira, Cassia G. T.; Magnani, Diogo M.; Costa, Priscilla R.; Silva, Vivian Helena Iida Avelino da 
; Ricciardi, Michael J.; Timenetsky, Maria do Carmo S. T.; Goulart, Raphaella; Correia, Carolina A.; Marmorato, Mariana P.; Ferrari, Lilian; Kalil Filho, Jorge Elias ; Kallas, Esper Georges
Source: Frontiers in immunology. Unidade: FM
Subjects: VACINAS VIRAIS, ADULTOS, INFLUENZA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Cassia G. T. et al. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.908398. Acesso em: 17 jun. 2024.APA
Silveira, C. G. T., Magnani, D. M., Costa, P. R., Silva, V. H. I. A. da, Ricciardi, M. J., Timenetsky, M. do C. S. T., et al. (2022). Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.908398NLM
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 jun. 17 ] Available from: https://doi.org/10.3389/fimmu.2022.908398Vancouver
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 jun. 17 ] Available from: https://doi.org/10.3389/fimmu.2022.908398
